Terns Pharmaceuticals (TERN) Stock Highlights

5.6 | -5.25%

2024-11-21 04:24:01

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Statistics

Range Today

5.56 5.92

Volume Today 1.23M

Range 1 Year

3.59 11.4

Volume 1 Year 303.28M

Range 3 Year

1.45 14.04

Volume 3 Year 484.15M

Range 10 Year

1.45 28.36

Volume 10 Year 507.07M

Highlights

Market Capitalization 616.38M (small)

Floating Shares 49.25M

Current Price 5.6

Price To Earnings -5.37

Price To Book 2.35

Earnings Per Share -1.32

Payout Ratio 0%

Performance

Latest -5.25%

1 Month -23.91%

3 Months -30.35%

6 Months -5.41%

1 Year +50.94%

3 Years -33.96%

5 Years -66.96%

10 Years -66.96%

Benchmarks

Market Capitalization

171 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

278 / 368

Free Cashflow

168 / 352

Performance 5 years

197 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.